<?open_access?>
<front>
  <?epub 28-December-2005
?>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="publisher-id">Nucleic Acids Research</journal-id>
    <journal-title>Nucleic Acids Research</journal-title>
    <issn pub-type="ppub">0305-1048</issn>
    <issn pub-type="epub">1362-4962</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">1347446</article-id>
    <article-id pub-id-type="doi">10.1093/nar/gkj083</article-id>
    <article-id pub-id-type="pmid">16381945</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>dbPTM: an information repository of protein post-translational modification</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Lee</surname>
          <given-names>Tzong-Yi</given-names>
        </name>
        <xref ref-type="aff" rid="au1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Huang</surname>
          <given-names>Hsien-Da</given-names>
        </name>
        <xref ref-type="aff" rid="au1">1</xref>
        <xref ref-type="aff" rid="au2">2</xref>
        <xref ref-type="corresp" rid="cor1">*</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Hung</surname>
          <given-names>Jui-Hung</given-names>
        </name>
        <xref ref-type="aff" rid="au1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Huang</surname>
          <given-names>Hsi-Yuan</given-names>
        </name>
        <xref ref-type="aff" rid="au1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Yang</surname>
          <given-names>Yuh-Shyong</given-names>
        </name>
        <xref ref-type="aff" rid="au2">2</xref>
        <xref ref-type="aff" rid="au3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Wang</surname>
          <given-names>Tzu-Hao</given-names>
        </name>
        <xref ref-type="aff" rid="au4">4</xref>
      </contrib>
      <aff id="au1">
        <sup>1</sup>
        <institution>Institute of Bioinformatics, National Chiao Tung University</institution>
        <addr-line>Hsin-Chu 300, Taiwan</addr-line>
      </aff>
      <aff id="au2">
        <sup>2</sup>
        <institution>Department of Biological Science and Technology, National Chiao Tung University</institution>
        <addr-line>Hsin-Chu 300, Taiwan</addr-line>
      </aff>
      <aff id="au3">
        <sup>3</sup>
        <institution>Institute of Biochemical Engineering, National Chiao Tung University</institution>
        <addr-line>Hsin-Chu 300, Taiwan</addr-line>
      </aff>
      <aff id="au4">
        <sup>4</sup>
        <institution>Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Lin-Kou Medical Center</institution>
        <addr-line>Tao-Yuan 333, Taiwan</addr-line>
      </aff>
    </contrib-group>
    <author-notes>
      <corresp id="cor1"><sup>*</sup>To whom correspondence should be addressed. Tel: +886 3 5712121, ext. 56952; Email: <email>bryan@mail.nctu.edu.tw</email></corresp>
      <fn>
        <p>Correspondence may also be addressed to Tzu-Hao Wang. Tel: +886 3 3281200, ext. 8984; Email: <email>knoxtn@cgmh.org.tw</email></p>
        <p>The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors</p>
      </fn>
    </author-notes>
    <!--For NAR: both ppub and collection dates generated for PMC processing 1/27/05 beck-->
    <pub-date pub-type="collection">
      <day>01</day>
      <month>1</month>
      <year>2006</year>
    </pub-date>
    <pub-date pub-type="ppub">
      <day>01</day>
      <month>1</month>
      <year>2006</year>
    </pub-date>
    <pub-date pub-type="epub">
      <day>28</day>
      <month>12</month>
      <year>2005</year>
    </pub-date>
    <volume>34</volume>
    <issue>Database issue</issue>
    <fpage>D622</fpage>
    <lpage>D627</lpage>
    <history>
      <date date-type="received">
        <day>15</day>
        <month>8</month>
        <year>2005</year>
      </date>
      <date date-type="rev-recd">
        <day>11</day>
        <month>10</month>
        <year>2005</year>
      </date>
      <date date-type="accepted">
        <day>11</day>
        <month>10</month>
        <year>2005</year>
      </date>
    </history>
    <copyright-statement>Â© The Author 2006. Published by Oxford University Press. All rights reserved</copyright-statement>
    <copyright-year>2006</copyright-year>
    <license license-type="openaccess">
      <p>The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact <email>journals.permissions@oxfordjournals.org</email></p>
    </license>
    <abstract>
      <p>dbPTM is a database that compiles information on protein post-translational modifications (PTMs), such as the catalytic sites, solvent accessibility of amino acid residues, protein secondary and tertiary structures, protein domains and protein variations. The database includes all of the experimentally validated PTM sites from Swiss-Prot, PhosphoELM and O-GLYCBASE. Only a small fraction of Swiss-Prot proteins are annotated with experimentally verified PTM. Although the Swiss-Prot provides rich information about the PTM, other structural properties and functional information of proteins are also essential for elucidating protein mechanisms. The dbPTM systematically identifies three major types of protein PTM (phosphorylation, glycosylation and sulfation) sites against Swiss-Prot proteins by refining our previously developed prediction tool, KinasePhos (<ext-link ext-link-type="uri" xlink:href="http://kinasephos.mbc.nctu.edu.tw/"/>). Solvent accessibility and secondary structure of residues are also computationally predicted and are mapped to the PTM sites. The resource is now freely available at <ext-link ext-link-type="uri" xlink:href="http://dbPTM.mbc.nctu.edu.tw/"/>.</p>
    </abstract>
  </article-meta>
</front>
<body>
  <sec>
    <title>INTRODUCTION</title>
    <p>Protein post-translational modification (PTM) is an extremely important cellular control mechanism because it may alter proteins' physical and chemical properties, folding, conformation, distribution, stability, activity and consequently, their functions (<xref ref-type="bibr" rid="b1">1</xref>). Examples of the biological effects of protein modifications include phosphorylation for signal transduction, attachment of fatty acids for membrane anchoring and association, and glycosylation for changing protein half-life, targeting substrates, and promoting cell-cell and cell-matrix interactions. With the accelerating progress in proteomics, biological knowledgebases containing a wealth of information, in particular protein modifications, are playing crucial roles in cell regulation research (<xref ref-type="bibr" rid="b2">2</xref>).</p>
    <p>The Swiss-Prot knowledge base (<xref ref-type="bibr" rid="b3">3</xref>) includes as much modification information as is available with consistency and structure, allowing easy retrieval by biologists. Phospho.ELM (<xref ref-type="bibr" rid="b1">1</xref>), which was developed as part of the ELM (Eukaryotic Linear Motif) resource, is a new resource containing experimentally verified phosphorylation sites that were manually curated from the literature. O-GLYCBASE (<xref ref-type="bibr" rid="b4">4</xref>) is a database of glycoproteins, most of which include experimentally verified O-linked glycosylation sites. The RESID protein modification database is a comprehensive collection of annotations and structures for protein modifications and cross-links including pre-, co- and post-translational modifications (<xref ref-type="bibr" rid="b5">5</xref>). The RESID database provides modification information, literature citations, Gene Ontology (GO) cross-references, protein sequence database feature table annotations, structure diagrams and molecular models. Each RESID entry presents a protein with a chemically unique modification and indicates how the modification is currently annotated in the Swiss-Prot (<xref ref-type="bibr" rid="b6">6</xref>).</p>
    <p>In this study, we collect the known PTM information from external biological data sources. Since only a small fraction of Swiss-Prot proteins are annotated with experimentally verified PTMs, we also developed computational tools to comprehensively identify phosphorylation sites, glycosylation sites and sulfation sites against the Swiss-Prot proteins. Protein structural properties and functional information, such as the solvent accessibility of residues, protein variations, non-synonymous single nucleotide polymorphism (SNP), protein tertiary structures and protein functional domains, are provided for researchers who are investigating the protein PTM mechanisms. Web query interface and graphical visualization were designed and implemented to facilitate access to the database content.</p>
  </sec>
  <sec>
    <title>DATA GENERATION</title>
    <p>The data generation flow of the dbPTM is briefly depicted in <xref ref-type="fig" rid="fig1">Figure 1</xref>. The data generation flow comprises the three major components: integration of external known PTM databases, learning and prediction of PTM sites, and structural or functional annotations. The experimentally validated PTM data sources were extracted from Swiss-Prot (<xref ref-type="bibr" rid="b3">3</xref>), Phospho.ELM (<xref ref-type="bibr" rid="b1">1</xref>) and O-GLYCBASE (<xref ref-type="bibr" rid="b4">4</xref>). The experimentally verified PTM sites were used to generate computer models to further identify putative PTM sites against the Swiss-Prot proteins. Additional structural properties and functional information, such as protein tertiary structures, protein secondary structures, solvent accessibility of residues, protein functional domains, protein variations and non-synonymous SNP, are also annotated to the Swiss-Prot proteins. The detailed data generation flow is described below.</p>
    <sec>
      <title>Integration of external known PTM databases</title>
      <p>Three external biological databases related to protein PTM information, Swiss-Prot (<xref ref-type="bibr" rid="b3">3</xref>), Phospho.ELM (<xref ref-type="bibr" rid="b1">1</xref>) and O-GLYCBASE (<xref ref-type="bibr" rid="b4">4</xref>), are integrated into the proposed resource. Both the experimentally validated PTM sites and the putative PTM sites, which are annotated as âby similarityâ, âpotentialâ or âprobableâ in the âMOD_RESâ fields, have been extracted from the Swiss-Prot database (<xref ref-type="bibr" rid="b3">3</xref>). As summarized in <xref ref-type="table" rid="tbl1">Table 1</xref>, release 46.0 of Swiss-Prot contributes 11â025 experimental validated PTM sites within 4921 proteins, and 72â308 putative PTM sites within 31â026 proteins. The Phospho.ELM entries store information about substrate proteins with the exact positions of residues are known to be phosphorylated by cellular kinases. A total of 1703 experimentally verified phosphorylation sites within 556 proteins were obtained from Phospho.ELM version 2 (<xref ref-type="bibr" rid="b1">1</xref>). O-GLYCBASE (<xref ref-type="bibr" rid="b4">4</xref>) Version 6.00 provides 242 glycoproteins containing 2765 experimentally verified O-linked, N-linked and C-linked glycosylation sites. Moreover, 185 glycoproteins in O-GLYCBASE are corresponded to Swiss-Prot proteins, which have 2353 experimentally verified glycosylation sites.</p>
    </sec>
    <sec>
      <title>Learning and prediction of PTM sites</title>
      <p>To provide the PTM information of the PTM un-annotated proteins available from Swiss-Prot, we integrated several computational tools for identifying the PTMs of the Swiss-Prot proteins. Our previous work, namely KinasePhos (<xref ref-type="bibr" rid="b7">7</xref>), incorporated the profile hidden Markov model (HMM) to identify kinase-specific phosphorylation sites with â¼87% prediction accuracy (<xref ref-type="bibr" rid="b8">8</xref>), which was compared with several phosphorylation prediction tools, such as NetPhos (<xref ref-type="bibr" rid="b9">9</xref>), DISPHOS (<xref ref-type="bibr" rid="b10">10</xref>) and rBPNN (<xref ref-type="bibr" rid="b11">11</xref>) (see Supplementary Table S1). KinasePhos is integrated and used to fully detect the kinase-specific phosphorylation sites against the Swiss-Prot proteins. To reduce the number of false positive predictions by KinasePhos, we set the predictive parameters as the values when the prediction specificity is 100% (<xref ref-type="bibr" rid="b8">8</xref>).</p>
      <p>As depicted in Supplementary Figure S1, the KinasePhos-like method, which is similar to KinasePhos for phosphorylation sites, was designed and implemented to learn models for the prediction of the sulfation sites, N-linked glycosylation sites and C-linked glycosylation sites (<xref ref-type="table" rid="tbl2">Table 2</xref>). We used the 144 known sulfation sites of tyrosine, 1790 N-linked glycosylation sites of asparagine and 49 C-linked glycosylation sites of tryptophan to evaluate the performance of the KinasePhos-like prediction tools. The result suggests that all three KinasePhos-like tools exhibited high prediction precision, sensitivity and specificity (Supplementary Table S2).</p>
    </sec>
    <sec>
      <title>Structural and functional annotations</title>
      <p>In order to provide more effective information about protein structural and functional annotations relevant to protein PTM, a variety of biological databases, such as Swiss-Prot (<xref ref-type="bibr" rid="b12">12</xref>), Ensembl (<xref ref-type="bibr" rid="b13">13</xref>), InterPro (<xref ref-type="bibr" rid="b14">14</xref>), PDB (<xref ref-type="bibr" rid="b15">15</xref>) and RESID (<xref ref-type="bibr" rid="b5">5</xref>), are integrated.</p>
      <p>Protein variation is the change of amino acids in polypeptides. As summarized in <xref ref-type="table" rid="tbl1">Table 1</xref>, Swiss-Prot contributes 32â101 protein variants corresponding to 6115 proteins, where 47 variant residues are located at the PTM sites and 267 variant residues are located surrounding 236 PTM sites (â4 â¼ +4 AA). Furthermore, single amino acid polymorphism (SAP) is the amino acid variation corresponding to the genetic variation as the definition of non-synonymous SNP in genomic sequence. The amino acid variants may have an impact on protein folding, active sites, or the overall solubility and stability of a protein. SAP is the type of variation most frequently related to human diseases (<xref ref-type="bibr" rid="b12">12</xref>). Therefore, when the amino acid variations occur in the PTM sites or the surrounding residues, they may affect the recognition of PTM sites by catalytic kinases. A total of 23â378 human non-synonymous SNPs located at 7230 Swiss-Prot human proteins were obtained from the variation part of Ensembl database (<xref ref-type="bibr" rid="b13">13</xref>).</p>
      <p>InterPro provides 1â113â928 entries corresponding to 161â988 Swiss-Prot proteins. We found that about 65% of Swiss-Prot annotated PTM sites are located at InterPro annotated protein domains. The RESID (<xref ref-type="bibr" rid="b5">5</xref>) protein modifications database is integrated into dbPTM to provide PTM related information, such as mass difference, chemical formula, enzymatic activities, literature citations, GO cross-references, structure diagrams and molecular models.</p>
      <p>The latest version of PDB contains 31â721 tertiary structures corresponding to 6806 Swiss-Prot protein entries (<xref ref-type="table" rid="tbl1">Table 1</xref>). For the proteins with known tertiary structures, the DSSP (<xref ref-type="bibr" rid="b16">16</xref>) program was used to extract the true secondary structure and solvent accessibility for those 6808 Swiss-Prot proteins. Solvent accessibility of amino acids residues is important for both the structure and function of proteins, especially the PTMs studied in this investigation. Protein secondary structure is the regular arrangement of amino acid residues in a segment of a polypeptide chain, where each amino acid is assigned a structure state, helix (H), strand (E) or coil (C). There are 1124 experimentally verified PTMs have the true secondary structure and solvent accessibility.</p>
      <p>However, only â¼4% of Swiss-Prot proteins have the known tertiary structures. For proteins without known tertiary structures, two previously published tools, RVP-net (<xref ref-type="bibr" rid="b17">17</xref>) and PSIPRED (<xref ref-type="bibr" rid="b18">18</xref>), were applied to predict the solvent accessibility and the secondary structure, respectively (see <xref ref-type="table" rid="tbl2">Table 2</xref>). RVP-net (<xref ref-type="bibr" rid="b17">17</xref>) presents a feed-forward type neural network which can predict a real value ranging from 0 to 100% of accessible surface areas (ASAs) for amino acid residues, based on their neighborhood information. We applied the RVP-net program (<xref ref-type="bibr" rid="b17">17</xref>) to fully predict the real-valued ASA for the amino acid residues of all Swiss-Prot proteins. By selecting a suggested threshold (<xref ref-type="bibr" rid="b17">17</xref>) (i.e. 25%), the residues with larger ASA values are viewed as surface residues.</p>
    </sec>
  </sec>
  <sec>
    <title>DATA STATISTICS</title>
    <p>The statistics of the experimentally verified PTMs and the putative PTMs compiled in the dbPTM resource are shown in the <xref ref-type="table" rid="tbl3">Table 3</xref>. For instance, dbPTM contains 14â057 known PTM sites and 772â154 putative PTM sites. The parameters of the predictive tools, KinasePhos, KinasePhos-like Sulfation and KinasePhos-like Glycosylationâfor the prediction of phosphorylation sites, sulfation sites and glycosylation sites, respectivelyâare set as the values when the predictive specificity is set to 100% during the parameter optimization of the trained models (<xref ref-type="bibr" rid="b8">8</xref>). The numbers of putative phosphorylation and sulfation sites, where the ASA of the substrates are &gt;25% (defined as the residue locating at the protein surface), are 652â756 and 13â315, respectively. There are a total of 33â887 predicted N-linked glycosylations of asparagine and C-linked glycosylations of tryptophan.</p>
  </sec>
  <sec>
    <title>INTERFACE</title>
    <p>To facilitate the use of the dbPTM resource, we developed a website for users to browse and search for content. As depicted in Supplementary Figure S2, the user can select a particular type of PTM for browsing the information. When clicking on a PTM entry, it pops up a window showing the solvent accessibility of the residues, the secondary structures and the flanking sequence of the PTM site.</p>
    <p>The search pages allow users to query the database using the Swiss-Prot ID and protein name. The interface also presents structural properties and functional information corresponding to the resulting proteins, such as the solvent accessibility of residues, non-synonymous variations, protein domains and protein secondary structures. Furthermore, the positional relationships among the PTMs, protein structural properties and protein functional information are graphically displayed (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p>
    <p>Generally, a 3D presentation is an effective manner for revealing the PTM information corresponding to the protein tertiary structures. For these purposes, we developed a protein structure viewer for the visualization of protein tertiary structures and especially of the port-translational modification residues. As shown in Supplementary Figure S3, the visualization tool provides a comprehensive view of the whole protein structure and marks residues that are annotated as the PTM sites. This visualization tool is implemented as a client-side tool based on OpenGL's pipeline.</p>
    <p>The visualization of the protein structures and the annotated residues are provided by two different ways according to different users' platforms. For users in MS Windows, the users can download the installable package of the Silver. After the Silver is installed, the protein tertiary structures and the PTM sites can be graphically and directly provided, as shown in Supplementary Figure S3. Alternatively, for users in other platforms such as Mac OS X, Linux and Solaris, the user can download the PDB structure and the Rasmol (<ext-link ext-link-type="uri" xlink:href="http://www.umass.edu/microbio/rasmol/"/>) scripts for the labeling of the PTM sites.</p>
  </sec>
  <sec>
    <title>CONCLUSIONS</title>
    <p>The proposed resource not only integrates the experimentally validated PTM information, but it also computationally annotates the Swiss-Prot proteins for putative phosphorylation, glycosylation and sulfation sites. Furthermore, the PTM related protein structural properties and functional information, such as solvent accessibility of amino acid residues, protein variations, protein secondary structures, protein tertiary structures and protein domains, are provided to facilitate the research of protein PTMs.</p>
    <p>One of the prospective goals for dbPTM is to integrate more efficient prediction tools for other types of PTM in addition to phosphorylation, sulfation and N- and C-linked glycosylation. Other protein sequence databases besides the Swiss-Prot protein database can also be considered and annotated for post-translation modifications by the proposed resource.</p>
  </sec>
  <sec>
    <title>AVAILABILITY</title>
    <p>The dbPTM resource will be regularly maintained and updated. The resource is now freely available at <ext-link ext-link-type="uri" xlink:href="http://dbPTM.mbc.nctu.edu.tw/"/>.</p>
  </sec>
  <sec>
    <title>SUPPLEMENTARY DATA</title>
    <p>Supplementary Data are available at NAR Online.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="PMC_1" content-type="local-data">
      <caption>
        <title>[Supplementary Material]</title>
      </caption>
      <media mimetype="text" mime-subtype="html" xlink:href="nar_34_suppl-1_D622__index.html"/>
      <media xlink:role="associated-file" mimetype="application" mime-subtype="msword" xlink:href="1afb63f34725e35e86fdba18b4c87cc7_gkj083_supp_mat.doc"/>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack>
    <p>The authors would like to thank Shih-Yee M. Wang (University of Illinois at Chicago) for English editing, the National Science Council of the Republic of China for financially supporting this research under Contract No. NSC 94-2213-E-009-025 (to H.-D.H.), and Chang Gung Memorial Hospital for the Research Grant CTRP1006 (to T.-H.W.). Funding to pay the Open Access publication charges for this article was provided by Chang Gung Memorial Hospital.</p>
    <p><italic>Conflict of interest statement</italic>. None declared.</p>
  </ack>
  <ref-list>
    <title>REFERENCES</title>
    <ref id="b1">
      <label>1</label>
      <citation citation-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Diella</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Cameron</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Gemund</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Linding</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Via</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Kuster</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Sicheritz-Ponten</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Blom</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Gibson</surname>
            <given-names>T.J.</given-names>
          </name>
        </person-group>
        <article-title>Phospho.ELM: a database of experimentally verified phosphorylation sites in eukaryotic proteins</article-title>
        <source>BMC Bioinformatics</source>
        <year>2004</year>
        <volume>5</volume>
        <fpage>79</fpage>
        <pub-id pub-id-type="pmid">15212693</pub-id>
      </citation>
    </ref>
    <ref id="b2">
      <label>2</label>
      <citation citation-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Farriol-Mathis</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Garavelli</surname>
            <given-names>J.S.</given-names>
          </name>
          <name>
            <surname>Boeckmann</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Duvaud</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Gasteiger</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Gateau</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Veuthey</surname>
            <given-names>A.L.</given-names>
          </name>
          <name>
            <surname>Bairoch</surname>
            <given-names>A.</given-names>
          </name>
        </person-group>
        <article-title>Annotation of post-translational modifications in the Swiss-Prot knowledge base</article-title>
        <source>Proteomics</source>
        <year>2004</year>
        <volume>4</volume>
        <fpage>1537</fpage>
        <lpage>1550</lpage>
        <pub-id pub-id-type="pmid">15174124</pub-id>
      </citation>
    </ref>
    <ref id="b3">
      <label>3</label>
      <citation citation-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Boeckmann</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Bairoch</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Apweiler</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Blatter</surname>
            <given-names>M.C.</given-names>
          </name>
          <name>
            <surname>Estreicher</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Gasteiger</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Martin</surname>
            <given-names>M.J.</given-names>
          </name>
          <name>
            <surname>Michoud</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>O'Donovan</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Phan</surname>
            <given-names>I.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2003</year>
        <volume>31</volume>
        <fpage>365</fpage>
        <lpage>370</lpage>
        <pub-id pub-id-type="pmid">12520024</pub-id>
      </citation>
    </ref>
    <ref id="b4">
      <label>4</label>
      <citation citation-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gupta</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Birch</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Rapacki</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Brunak</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Hansen</surname>
            <given-names>J.E.</given-names>
          </name>
        </person-group>
        <article-title>O-GLYCBASE version 4.0: a revised database of O-glycosylated proteins</article-title>
        <source>Nucleic Acids Res</source>
        <year>1999</year>
        <volume>27</volume>
        <fpage>370</fpage>
        <lpage>372</lpage>
        <pub-id pub-id-type="pmid">9847232</pub-id>
      </citation>
    </ref>
    <ref id="b5">
      <label>5</label>
      <citation citation-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Garavelli</surname>
            <given-names>J.S.</given-names>
          </name>
        </person-group>
        <article-title>The RESID database of protein modifications as a resource and annotation tool</article-title>
        <source>Proteomics</source>
        <year>2004</year>
        <volume>4</volume>
        <fpage>1527</fpage>
        <lpage>1533</lpage>
        <pub-id pub-id-type="pmid">15174122</pub-id>
      </citation>
    </ref>
    <ref id="b6">
      <label>6</label>
      <citation citation-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wu</surname>
            <given-names>C.H.</given-names>
          </name>
          <name>
            <surname>Yeh</surname>
            <given-names>L.S.</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Arminski</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Castro-Alvear</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Hu</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Kourtesis</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Ledley</surname>
            <given-names>R.S.</given-names>
          </name>
          <name>
            <surname>Suzek</surname>
            <given-names>B.E.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The Protein Information Resource</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2003</year>
        <volume>31</volume>
        <fpage>345</fpage>
        <lpage>347</lpage>
        <pub-id pub-id-type="pmid">12520019</pub-id>
      </citation>
    </ref>
    <ref id="b7">
      <label>7</label>
      <citation citation-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Huang</surname>
            <given-names>H.D.</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>T.Y.</given-names>
          </name>
          <name>
            <surname>Tzeng</surname>
            <given-names>S.W.</given-names>
          </name>
          <name>
            <surname>Horng</surname>
            <given-names>J.T.</given-names>
          </name>
        </person-group>
        <article-title>KinasePhos: a web tool for identifying protein kinase-specific phosphorylation sites</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2005</year>
        <volume>33</volume>
        <fpage>W226</fpage>
        <lpage>W229</lpage>
        <pub-id pub-id-type="pmid">15980458</pub-id>
      </citation>
    </ref>
    <ref id="b8">
      <label>8</label>
      <citation citation-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Huang</surname>
            <given-names>H.D.</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>T.Y.</given-names>
          </name>
          <name>
            <surname>Tzeng</surname>
            <given-names>S.W.</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>L.C.</given-names>
          </name>
          <name>
            <surname>Horng</surname>
            <given-names>J.T.</given-names>
          </name>
          <name>
            <surname>Tsou</surname>
            <given-names>A.P.</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>K.T.</given-names>
          </name>
        </person-group>
        <article-title>Incorporating hidden Markov models for identifying protein kinase-specific phosphorylation sites</article-title>
        <source>J. Comput. Chem.</source>
        <year>2005</year>
        <volume>26</volume>
        <fpage>1032</fpage>
        <lpage>1041</lpage>
        <pub-id pub-id-type="pmid">15889432</pub-id>
      </citation>
    </ref>
    <ref id="b9">
      <label>9</label>
      <citation citation-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Blom</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Gammeltoft</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Brunak</surname>
            <given-names>S.</given-names>
          </name>
        </person-group>
        <article-title>Sequence and structure-based prediction of eukaryotic protein phosphorylation sites</article-title>
        <source>J. Mol. Biol.</source>
        <year>1999</year>
        <volume>294</volume>
        <fpage>1351</fpage>
        <lpage>1362</lpage>
        <pub-id pub-id-type="pmid">10600390</pub-id>
      </citation>
    </ref>
    <ref id="b10">
      <label>10</label>
      <citation citation-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Iakoucheva</surname>
            <given-names>L.M.</given-names>
          </name>
          <name>
            <surname>Radivojac</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Brown</surname>
            <given-names>C.J.</given-names>
          </name>
          <name>
            <surname>O'Connor</surname>
            <given-names>T.R.</given-names>
          </name>
          <name>
            <surname>Sikes</surname>
            <given-names>J.G.</given-names>
          </name>
          <name>
            <surname>Obradovic</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Dunker</surname>
            <given-names>A.K.</given-names>
          </name>
        </person-group>
        <article-title>The importance of intrinsic disorder for protein phosphorylation</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2004</year>
        <volume>32</volume>
        <fpage>1037</fpage>
        <lpage>1049</lpage>
        <pub-id pub-id-type="pmid">14960716</pub-id>
      </citation>
    </ref>
    <ref id="b11">
      <label>11</label>
      <citation citation-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Berry</surname>
            <given-names>E.A.</given-names>
          </name>
          <name>
            <surname>Dalby</surname>
            <given-names>A.R.</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>Z.R.</given-names>
          </name>
        </person-group>
        <article-title>Reduced bio basis function neural network for identification of protein phosphorylation sites: comparison with pattern recognition algorithms</article-title>
        <source>Comput. Biol. Chem.</source>
        <year>2004</year>
        <volume>28</volume>
        <fpage>75</fpage>
        <lpage>85</lpage>
        <pub-id pub-id-type="pmid">15022646</pub-id>
      </citation>
    </ref>
    <ref id="b12">
      <label>12</label>
      <citation citation-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yip</surname>
            <given-names>Y.L.</given-names>
          </name>
          <name>
            <surname>Scheib</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Diemand</surname>
            <given-names>A.V.</given-names>
          </name>
          <name>
            <surname>Gattiker</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Famiglietti</surname>
            <given-names>L.M.</given-names>
          </name>
          <name>
            <surname>Gasteiger</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Bairoch</surname>
            <given-names>A.</given-names>
          </name>
        </person-group>
        <article-title>The Swiss-Prot variant page and the ModSNP database: a resource for sequence and structure information on human protein variants</article-title>
        <source>Hum. Mutat.</source>
        <year>2004</year>
        <volume>23</volume>
        <fpage>464</fpage>
        <lpage>470</lpage>
        <pub-id pub-id-type="pmid">15108278</pub-id>
      </citation>
    </ref>
    <ref id="b13">
      <label>13</label>
      <citation citation-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hubbard</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Andrews</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Caccamo</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Cameron</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Clamp</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Clarke</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Coates</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Cox</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Cunningham</surname>
            <given-names>F.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Ensembl 2005</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2005</year>
        <volume>33</volume>
        <fpage>D447</fpage>
        <lpage>D453</lpage>
        <pub-id pub-id-type="pmid">15608235</pub-id>
      </citation>
    </ref>
    <ref id="b14">
      <label>14</label>
      <citation citation-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mulder</surname>
            <given-names>N.J.</given-names>
          </name>
          <name>
            <surname>Apweiler</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Attwood</surname>
            <given-names>T.K.</given-names>
          </name>
          <name>
            <surname>Bairoch</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Bateman</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Binns</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Biswas</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Bradley</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Bork</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Bucher</surname>
            <given-names>P.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>InterPro: an integrated documentation resource for protein families, domains and functional sites</article-title>
        <source>Brief Bioinform.</source>
        <year>2002</year>
        <volume>3</volume>
        <fpage>225</fpage>
        <lpage>235</lpage>
        <pub-id pub-id-type="pmid">12230031</pub-id>
      </citation>
    </ref>
    <ref id="b15">
      <label>15</label>
      <citation citation-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Deshpande</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Addess</surname>
            <given-names>K.J.</given-names>
          </name>
          <name>
            <surname>Bluhm</surname>
            <given-names>W.F.</given-names>
          </name>
          <name>
            <surname>Merino-Ott</surname>
            <given-names>J.C.</given-names>
          </name>
          <name>
            <surname>Townsend-Merino</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Q.</given-names>
          </name>
          <name>
            <surname>Knezevich</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Xie</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Feng</surname>
            <given-names>Z.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The RCSB Protein Data Bank: a redesigned query system and relational database based on the mmCIF schema</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2005</year>
        <volume>33</volume>
        <fpage>D233</fpage>
        <lpage>D237</lpage>
        <pub-id pub-id-type="pmid">15608185</pub-id>
      </citation>
    </ref>
    <ref id="b16">
      <label>16</label>
      <citation citation-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kabsch</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Sander</surname>
            <given-names>C.</given-names>
          </name>
        </person-group>
        <article-title>Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features</article-title>
        <source>Biopolymers</source>
        <year>1983</year>
        <volume>22</volume>
        <fpage>2577</fpage>
        <lpage>2637</lpage>
        <pub-id pub-id-type="pmid">6667333</pub-id>
      </citation>
    </ref>
    <ref id="b17">
      <label>17</label>
      <citation citation-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ahmad</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Gromiha</surname>
            <given-names>M.M.</given-names>
          </name>
          <name>
            <surname>Sarai</surname>
            <given-names>A.</given-names>
          </name>
        </person-group>
        <article-title>RVP-net: online prediction of real valued accessible surface area of proteins from single sequences</article-title>
        <source>Bioinformatics</source>
        <year>2003</year>
        <volume>19</volume>
        <fpage>1849</fpage>
        <lpage>1851</lpage>
        <pub-id pub-id-type="pmid">14512359</pub-id>
      </citation>
    </ref>
    <ref id="b18">
      <label>18</label>
      <citation citation-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>McGuffin</surname>
            <given-names>L.J.</given-names>
          </name>
          <name>
            <surname>Bryson</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Jones</surname>
            <given-names>D.T.</given-names>
          </name>
        </person-group>
        <article-title>The PSIPRED protein structure prediction server</article-title>
        <source>Bioinformatics</source>
        <year>2000</year>
        <volume>16</volume>
        <fpage>404</fpage>
        <lpage>405</lpage>
        <pub-id pub-id-type="pmid">10869041</pub-id>
      </citation>
    </ref>
  </ref-list>
  <sec sec-type="display-objects">
    <title>Figures and Tables</title>
    <fig id="fig1" position="float">
      <label>Figure 1</label>
      <caption>
        <p>The data generation flow of the dbPTM database.</p>
      </caption>
      <graphic xlink:href="gkj083f1"/>
    </fig>
    <fig id="fig2" position="float">
      <label>Figure 2</label>
      <caption>
        <p>The graphical interface reveals the PTMs, the solvent accessibility of the residues, protein variations, protein secondary structures and protein functional domains.</p>
      </caption>
      <graphic xlink:href="gkj083f2"/>
    </fig>
    <table-wrap id="tbl1" position="float">
      <label>Table 1</label>
      <caption>
        <p>The list of the integrated external data sources</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th align="left" colspan="1" rowspan="1">Databases</th>
            <th align="left" colspan="1" rowspan="1">Description</th>
            <th align="left" colspan="1" rowspan="1">Statistics</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="left" colspan="1" rowspan="1">Swiss-Prot (<xref ref-type="bibr" rid="b3">3</xref>,<xref ref-type="bibr" rid="b12">12</xref>)</td>
            <td align="left" colspan="1" rowspan="1">Experimental PTMs</td>
            <td align="left" colspan="1" rowspan="1">11â025 PTM sites within 4921 proteins</td>
          </tr>
          <tr>
            <td colspan="1" rowspan="1"/>
            <td align="left" colspan="1" rowspan="1">Putative PTMs</td>
            <td align="left" colspan="1" rowspan="1">72â308 PTM sites within 31â026 proteins</td>
          </tr>
          <tr>
            <td colspan="1" rowspan="1"/>
            <td align="left" colspan="1" rowspan="1">Proteins</td>
            <td align="left" colspan="1" rowspan="1">176â469 Proteins</td>
          </tr>
          <tr>
            <td colspan="1" rowspan="1"/>
            <td align="left" colspan="1" rowspan="1">Protein variants</td>
            <td align="left" colspan="1" rowspan="1">32â101 Variants corresponding to 6115 proteins</td>
          </tr>
          <tr>
            <td align="left" colspan="1" rowspan="1">PhosphoELM (<xref ref-type="bibr" rid="b1">1</xref>)</td>
            <td align="left" colspan="1" rowspan="1">Experimental phosphorylation sites</td>
            <td align="left" colspan="1" rowspan="1">1703 PTM sites within 556 proteins</td>
          </tr>
          <tr>
            <td align="left" colspan="1" rowspan="1">O-GLYCBASE (<xref ref-type="bibr" rid="b4">4</xref>)</td>
            <td align="left" colspan="1" rowspan="1">Experimental glycosylation sites</td>
            <td align="left" colspan="1" rowspan="1">2353 PTM sites within 185 glycoproteins</td>
          </tr>
          <tr>
            <td align="left" colspan="1" rowspan="1">RESID (<xref ref-type="bibr" rid="b5">5</xref>)</td>
            <td align="left" colspan="1" rowspan="1">PTMs</td>
            <td align="left" colspan="1" rowspan="1">373 PTM types</td>
          </tr>
          <tr>
            <td align="left" colspan="1" rowspan="1">InterPro (<xref ref-type="bibr" rid="b14">14</xref>)</td>
            <td align="left" colspan="1" rowspan="1">Protein domain</td>
            <td align="left" colspan="1" rowspan="1">1â113â928 Entries corresponding to 161â988 Swiss-Prot entries</td>
          </tr>
          <tr>
            <td align="left" colspan="1" rowspan="1">Ensembl (<xref ref-type="bibr" rid="b13">13</xref>)</td>
            <td align="left" colspan="1" rowspan="1">Human variations</td>
            <td align="left" colspan="1" rowspan="1">23â378 Non-synonymous SNPs within 7230 Swiss-Prot human proteins</td>
          </tr>
          <tr>
            <td align="left" colspan="1" rowspan="1">PDB (<xref ref-type="bibr" rid="b15">15</xref>)</td>
            <td align="left" colspan="1" rowspan="1">Protein structures</td>
            <td align="left" colspan="1" rowspan="1">31â721 Entries corresponding to 6806 Swiss-Prot proteins</td>
          </tr>
        </tbody>
      </table>
    </table-wrap>
    <table-wrap id="tbl2" position="float">
      <label>Table 2</label>
      <caption>
        <p>The list of the integrated annotated tools</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th align="left" colspan="1" rowspan="1">Tools</th>
            <th align="left" colspan="1" rowspan="1">Description</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="left" colspan="1" rowspan="1">KinasePhos (<xref ref-type="bibr" rid="b7">7</xref>)</td>
            <td align="left" colspan="1" rowspan="1">Identifying kinase-specific phosphorylation sites</td>
          </tr>
          <tr>
            <td align="left" colspan="1" rowspan="1">KinasePhos-like sulfation</td>
            <td align="left" colspan="1" rowspan="1">Identifying sulfation sites</td>
          </tr>
          <tr>
            <td align="left" colspan="1" rowspan="1">KinasePhos-like N-linked glycosylation</td>
            <td align="left" colspan="1" rowspan="1">Identifying N-linked glycosylation sites</td>
          </tr>
          <tr>
            <td align="left" colspan="1" rowspan="1">KinasePhos-like C-linked glycosylation</td>
            <td align="left" colspan="1" rowspan="1">Identifying C-linked glycosylation sites</td>
          </tr>
          <tr>
            <td align="left" colspan="1" rowspan="1">DSSP (<xref ref-type="bibr" rid="b16">16</xref>)</td>
            <td align="left" colspan="1" rowspan="1">Calculating the secondary structure and solvent accessibility of residues</td>
          </tr>
          <tr>
            <td align="left" colspan="1" rowspan="1">RVP-net (<xref ref-type="bibr" rid="b17">17</xref>)</td>
            <td align="left" colspan="1" rowspan="1">Predicting the solvent accessibility of residues</td>
          </tr>
          <tr>
            <td align="left" colspan="1" rowspan="1">PSIPRED (<xref ref-type="bibr" rid="b18">18</xref>)</td>
            <td align="left" colspan="1" rowspan="1">Predicting the protein secondary structures</td>
          </tr>
          <tr>
            <td align="left" colspan="1" rowspan="1">Weblogo (<xref ref-type="bibr" rid="b15">15</xref>)</td>
            <td align="left" colspan="1" rowspan="1">Generating sequence logo for PTM substrates</td>
          </tr>
        </tbody>
      </table>
    </table-wrap>
    <table-wrap id="tbl3" position="float">
      <label>Table 3</label>
      <caption>
        <p>The data statistics of the dbPTM database</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th align="left" colspan="1" rowspan="1">PTM types</th>
            <th align="left" colspan="1" rowspan="1">Substrates</th>
            <th align="left" colspan="1" rowspan="1">No. of known PTMs</th>
            <th align="left" colspan="1" rowspan="1">No. of putative PTMs</th>
            <th align="left" colspan="1" rowspan="1">Total</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="left" colspan="1" rowspan="1">Phosphorylation</td>
            <td align="left" colspan="1" rowspan="1">Serine, threonine, tyrosine, aspartate, histidine or cysteine</td>
            <td align="right" colspan="1" rowspan="1">3367</td>
            <td align="right" colspan="1" rowspan="1">5852</td>
            <td colspan="1" rowspan="1"/>
          </tr>
          <tr>
            <td colspan="1" rowspan="1"/>
            <td align="left" colspan="1" rowspan="1">Serine, threonine and tyrosine (predicted in this resource, ASA &gt; 0%)</td>
            <td colspan="1" rowspan="1"/>
            <td align="right" colspan="1" rowspan="1">1â346â067</td>
            <td align="left" colspan="1" rowspan="1">661â975 (ASA &gt; 25%)</td>
          </tr>
          <tr>
            <td colspan="1" rowspan="1"/>
            <td align="left" colspan="1" rowspan="1">Serine, threonine and tyrosine (predicted in this resource, ASA &gt; 25%)</td>
            <td colspan="1" rowspan="1"/>
            <td align="right" colspan="1" rowspan="1">652â756</td>
            <td colspan="1" rowspan="1"/>
          </tr>
          <tr>
            <td align="left" colspan="1" rowspan="1">Glycosylation</td>
            <td align="left" colspan="1" rowspan="1">N-linked, O-linked and C-linked glycosylation</td>
            <td align="right" colspan="1" rowspan="1">4586</td>
            <td align="right" colspan="1" rowspan="1">55â059</td>
            <td colspan="1" rowspan="1"/>
          </tr>
          <tr>
            <td colspan="1" rowspan="1"/>
            <td align="left" colspan="1" rowspan="1">N-linked asparagines and C-linked tryptophane (predicted in this resource, ASA &gt; 0%)</td>
            <td colspan="1" rowspan="1"/>
            <td align="right" colspan="1" rowspan="1">43â894</td>
            <td align="left" colspan="1" rowspan="1">94â132 (ASA &gt; 25%)</td>
          </tr>
          <tr>
            <td colspan="1" rowspan="1"/>
            <td align="left" colspan="1" rowspan="1">N-linked asparagines and C-linked tryptophane (predicted in this resource, ASA &gt; 25%)</td>
            <td colspan="1" rowspan="1"/>
            <td align="right" colspan="1" rowspan="1">33â887</td>
            <td colspan="1" rowspan="1"/>
          </tr>
          <tr>
            <td align="left" colspan="1" rowspan="1">Sulfation</td>
            <td align="left" colspan="1" rowspan="1">Serine, threonine and tyrosine</td>
            <td align="right" colspan="1" rowspan="1">144</td>
            <td align="right" colspan="1" rowspan="1">413</td>
            <td colspan="1" rowspan="1"/>
          </tr>
          <tr>
            <td colspan="1" rowspan="1"/>
            <td align="left" colspan="1" rowspan="1">Tyrosine (predicted in this resource, ASA &gt; 0%)</td>
            <td colspan="1" rowspan="1"/>
            <td align="right" colspan="1" rowspan="1">189â457</td>
            <td align="left" colspan="1" rowspan="1">13â872 (ASA &gt; 25%)</td>
          </tr>
          <tr>
            <td colspan="1" rowspan="1"/>
            <td align="left" colspan="1" rowspan="1">Tyrosine (predicted in this resource, ASA &gt; 25%)</td>
            <td colspan="1" rowspan="1"/>
            <td align="right" colspan="1" rowspan="1">13â315</td>
            <td colspan="1" rowspan="1"/>
          </tr>
          <tr>
            <td align="left" colspan="1" rowspan="1">Lipidation</td>
            <td align="left" colspan="1" rowspan="1">GPI-anchor, N-terminal myristoylation and palmitoylation</td>
            <td align="right" colspan="1" rowspan="1">520</td>
            <td align="right" colspan="1" rowspan="1">4688</td>
            <td align="left" colspan="1" rowspan="1">5208</td>
          </tr>
          <tr>
            <td align="left" colspan="1" rowspan="1">Acetylation</td>
            <td align="left" colspan="1" rowspan="1">N-terminal of some residues and side chain of lysine or cysteine</td>
            <td align="right" colspan="1" rowspan="1">1019</td>
            <td align="right" colspan="1" rowspan="1">1580</td>
            <td align="left" colspan="1" rowspan="1">2599</td>
          </tr>
          <tr>
            <td align="left" colspan="1" rowspan="1">Amidation</td>
            <td align="left" colspan="1" rowspan="1">Generally at the C-terminal of a mature active peptide after oxidative cleavage of last glycine</td>
            <td align="right" colspan="1" rowspan="1">1554</td>
            <td align="right" colspan="1" rowspan="1">523</td>
            <td align="left" colspan="1" rowspan="1">2077</td>
          </tr>
          <tr>
            <td align="left" colspan="1" rowspan="1">Methylation</td>
            <td align="left" colspan="1" rowspan="1">Generally of N-terminal phenylalanine, side chain of lysine, arginine, histidine, ralinenes or glutamate and C-terminal cysteine</td>
            <td align="right" colspan="1" rowspan="1">455</td>
            <td align="right" colspan="1" rowspan="1">1105</td>
            <td align="left" colspan="1" rowspan="1">1560</td>
          </tr>
          <tr>
            <td align="left" colspan="1" rowspan="1">Hydroxylation</td>
            <td align="left" colspan="1" rowspan="1">Generally of ralinenes, aspartate, raline or lysine</td>
            <td align="right" colspan="1" rowspan="1">816</td>
            <td align="right" colspan="1" rowspan="1">515</td>
            <td align="left" colspan="1" rowspan="1">1331</td>
          </tr>
          <tr>
            <td align="left" colspan="1" rowspan="1">Pyrrolidone carboxylic acid</td>
            <td align="left" colspan="1" rowspan="1">N-terminal glutamine which has formed an internal cyclic lactam</td>
            <td align="right" colspan="1" rowspan="1">567</td>
            <td align="right" colspan="1" rowspan="1">408</td>
            <td align="left" colspan="1" rowspan="1">975</td>
          </tr>
          <tr>
            <td align="left" colspan="1" rowspan="1">Gamma-carboxyglutamic acid</td>
            <td align="left" colspan="1" rowspan="1">4-Carboxyglutamate</td>
            <td align="right" colspan="1" rowspan="1">343</td>
            <td align="right" colspan="1" rowspan="1">263</td>
            <td align="left" colspan="1" rowspan="1">606</td>
          </tr>
          <tr>
            <td align="left" colspan="1" rowspan="1">Trimethylation</td>
            <td align="left" colspan="1" rowspan="1">N6-methylated lysine, N6,N6,N6-trimethyllysine, N,N,N-trimethylalanine</td>
            <td align="right" colspan="1" rowspan="1">158</td>
            <td align="right" colspan="1" rowspan="1">294</td>
            <td align="left" colspan="1" rowspan="1">452</td>
          </tr>
          <tr>
            <td align="left" colspan="1" rowspan="1">Blocked</td>
            <td align="left" colspan="1" rowspan="1">Unidentified N- or C-terminal blocking group</td>
            <td align="right" colspan="1" rowspan="1">108</td>
            <td align="right" colspan="1" rowspan="1">10</td>
            <td align="left" colspan="1" rowspan="1">118</td>
          </tr>
          <tr>
            <td align="left" colspan="1" rowspan="1">FAD</td>
            <td align="left" colspan="1" rowspan="1">O-8alpha-FAD tyrosine, Pros-8alpha-FAD histidine, S-8alpha-FAD cysteine and Tele-8alpha-FAD histidine</td>
            <td align="right" colspan="1" rowspan="1">12</td>
            <td align="right" colspan="1" rowspan="1">77</td>
            <td align="left" colspan="1" rowspan="1">89</td>
          </tr>
          <tr>
            <td align="left" colspan="1" rowspan="1">S-nitrosylation</td>
            <td align="left" colspan="1" rowspan="1">S-nitrosocysteine</td>
            <td align="right" colspan="1" rowspan="1">5</td>
            <td align="right" colspan="1" rowspan="1">59</td>
            <td align="left" colspan="1" rowspan="1">64</td>
          </tr>
          <tr>
            <td align="left" colspan="1" rowspan="1">Formylation</td>
            <td align="left" colspan="1" rowspan="1">Of the N-terminal methionine</td>
            <td align="right" colspan="1" rowspan="1">35</td>
            <td align="right" colspan="1" rowspan="1">27</td>
            <td align="left" colspan="1" rowspan="1">62</td>
          </tr>
          <tr>
            <td align="left" colspan="1" rowspan="1">Deamidation</td>
            <td align="left" colspan="1" rowspan="1">Deamidated asparagin and deamidated glutamine (needs to be followed by a G)</td>
            <td align="right" colspan="1" rowspan="1">33</td>
            <td align="right" colspan="1" rowspan="1">18</td>
            <td align="left" colspan="1" rowspan="1">51</td>
          </tr>
          <tr>
            <td align="left" colspan="1" rowspan="1">Citrullination</td>
            <td align="left" colspan="1" rowspan="1">Citrulline</td>
            <td align="right" colspan="1" rowspan="1">7</td>
            <td align="right" colspan="1" rowspan="1">41</td>
            <td align="left" colspan="1" rowspan="1">48</td>
          </tr>
          <tr>
            <td align="left" colspan="1" rowspan="1">Others</td>
            <td colspan="1" rowspan="1"/>
            <td align="right" colspan="1" rowspan="1">328</td>
            <td align="right" colspan="1" rowspan="1">1274</td>
            <td align="left" colspan="1" rowspan="1">1134</td>
          </tr>
          <tr>
            <td align="left" colspan="1" rowspan="1">Total</td>
            <td colspan="1" rowspan="1"/>
            <td align="right" colspan="1" rowspan="1">14â057</td>
            <td align="right" colspan="1" rowspan="1">772â154</td>
            <td align="left" colspan="1" rowspan="1">786â211</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn>
          <p>ASA, accessible surface area.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </sec>
</back>
